OKYO Appoints Marta Sacchetti, MD, PhD to Scientific Advisory Board, Advances Urcosimod for Neuropathic Corneal Pain Treatment
OKYO Pharma Limited Ordinary Shares · Now $1.71
+7.2% in 7d after detection
Post-detection moves
1h
—
1d
0.0%
3d
+1.9%
7d
+7.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS